REED ELIZABETH E

CIK 00012833033 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283303

Recent Transactions

50 trades

Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-06$43.95/sh−2,076→ 105,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-05$46.65/sh−2,174→ 107,287 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2026-05-04−4,250→ 4,250 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2026-05-04+8,500→ 8,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-04$17.96/sh+20,000→ 125,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-04+4,250→ 109,461 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-05-04−20,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-05-04$45.00/sh−20,000→ 105,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-15$41.62/sh−5,226→ 106,770 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-15$42.53/sh−1,559→ 105,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$15.46/sh+7,500→ 156,711 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-14−7,500→ 37,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-14−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$17.96/sh+20,000→ 149,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$19.08/sh+10,000→ 129,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$41.93/sh−7,215→ 111,996 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-14$41.07/sh−37,500→ 119,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-14−20,000→ 20,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-13+14,000→ 119,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-01$30.00/sh−10,000→ 105,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-04-01$15.46/sh+10,000→ 115,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-04-01−10,000→ 45,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-03-16$28.09/sh−10,000→ 105,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-03-16$19.08/sh+10,000→ 115,211 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-03-16−10,000→ 10,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-02-17−10,000→ 20,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-17$19.08/sh+10,000→ 115,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-17$27.50/sh−5,679→ 109,532 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-17$28.26/sh−4,321→ 105,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-04$32.74/sh−509→ 105,211 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-04$32.07/sh−2,485→ 105,720 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-02-03$32.12/sh−7,175→ 108,205 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-31+25,110→ 115,380 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-31+66,960→ 66,960 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-20$27.34/sh−10,000→ 90,270 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-20−10,000→ 30,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-20$19.08/sh+10,000→ 100,270 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-09-22$19.08/sh+10,000→ 99,878 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-09-22−10,000→ 40,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-09-22$25.00/sh−10,000→ 89,878 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-05$21.05/sh−4,920→ 89,482 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-02+4,920→ 94,402 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-05-02−4,920→ 4,920 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-12$23.53/sh−8,000→ 89,482 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-10+8,000→ 97,482 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-02-10−8,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$19.78/sh−8,951→ 89,482 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-01-31+58,000→ 58,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-31+21,500→ 98,433 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-22$19.46/sh−2,437→ 76,933 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov